@FierceBiotech: ICYMI yesterday: CDC director warns antibiotics pipeline 'nearly empty.' Story | Follow @FierceBiotech
@JohnCFierce: Regado CEO moves the goal line after a rare biotech IPO misfire. More | Follow @JohnCFierce
> Dendreon shares ($DNDN) jumped about 10% this morning after the biotech reported that the European Commission had approved Provenge, its struggling prostate cancer therapy, which has experienced profound trouble in developing a market in the U.S. Story
> The U.K.'s Acacia Pharma launched two pivotal Phase III studies of APD421 in the prevention of post-operative nausea and vomiting. Release
> The European Commission has also approved Sanofi's ($SNY) MS drug Lemtrada, which was developed by Genzyme. Story
@FierceMedDev: Special Report: 'Big' med tech M&A deals getting smaller. Feature | Follow @FierceMedDev
@DamianFierce: VisionCare landed up to $15M to market its AMD-treating eye implant. News | Follow @DamianFierce
@MarkHFierce: The U.S. will now have the first permanent implant designed to treat enlarged prostates. Expect a gradual launch. ICYMI yesterday | Follow @MarkHFierce
@MichaelGFierce: Abbott snags CE mark for diabetes monitor. Item | Follow @MichaelGFierce
> Europe risks more delays on device reg reform. More
> Medtronic cuts ribbon on $10M Irish R&D shop. Story
> Boston Scientific debuts teaching, R&D centers in China. Article
Pharma News
@FiercePharma: Now armed with EU nod for Lemtrada, Sanofi preps to launch its multiple sclerosis duo (with Aubagio). Release (PDF) | Follow @FiercePharma
@CarlyHFierce: Whistleblower codenamed Zorro implicates Novartis' Alcon division in Chinese bribery scandal. More from The Financial Times | Follow @CarlyHFierce
> Novartis faces second set of bribery claims in China. More
> FDA approves Teva's generic of Roche blockbuster Xeloda. Article
Pharma Manufacturing News
@EricPFierce: Now that Ranbaxy's Mohali plant falls under FDA consent decree, oversight ramps up significantly. Article | Follow @EricPFierce
> Cargill invests $15M in French alginate plant. Item
> Hospira recalls bupivacaine because of steel particles in vials. Story
> Strides gets FDA warning for plant Mylan is buying. More
> J&J sues Ben Venue over Doxil shortage. Report
Biotech Research News
@EmilyMFierce: Initial focus of BRAIN Initiative laid out, but are the goals any clearer than they were in April? Check out the story and weigh in | Follow @EmilyMFierce
> Visterra antibody shows promise in preclinical study as universal flu vaccine. Item
> NIH partners with Eli Lilly, others on rare diseases. Article
> Experimental vaccine clears monkeys of HIV-like virus. More
> Genia Technologies, Columbia, Harvard nab $5.3M NIH grant for genome sequencing. Story
And Finally... No, this isn't an image of a far-away galaxy. It's a map of 873,344 scientific papers across various disciplines.